According to Portage Biotech's latest financial reports the company's total liabilities are $17.7 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-03-31 | $23.73 M | -18.8% |
2022-03-31 | $29.22 M | 7.23% |
2021-03-31 | $27.25 M | -1% |
2020-03-31 | $27.53 M | 9.44% |
2019-03-31 | $25.15 M | 6451.56% |
2018-03-31 | $0.38 M | 23.87% |
2017-03-31 | $0.31 M | 3.42% |
2016-03-31 | $0.29 M | -51.7% |
2015-03-31 | $0.62 M | 223.26% |
2014-03-31 | $0.19 M | -57.04% |
2013-03-31 | $0.44 M | -83.21% |
2012-03-31 | $2.66 M | 289.85% |
2011-03-31 | $0.68 M | -80.52% |
2010-03-31 | $3.5 M | 2811.47% |
2009-03-31 | $0.12 M | 109.95% |
2008-03-31 | $0.05 M | 36.53% |
2007-03-31 | $0.04 M | -70.32% |
2006-03-31 | $0.14 M | 37.71% |
2005-03-31 | $0.1 M | -84.44% |
2004-03-31 | $0.66 M | 182.56% |
2003-03-31 | $0.23 M | 84.85% |
2002-03-31 | $0.12 M | 33.67% |
2001-03-31 | $0.09 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $3.14 M | -82.22% | Bahamas |
NRC Health
NRC | $83.96 M | 374.25% | ๐บ๐ธ USA |